Russell Investments Group
CBMG

Russell Investments Group’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Russell Investments Group’s Portfolio CBMG Stock Details CBMG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-108,545
Closed -$1.99M – 3263
2020
Q4 		$1.99M Buy
108,545
+4,747
+5% +$86.5K ﹤0.01% 1761
2020
Q3 		$1.9M Sell
103,798
-29,473
-22% -$495K ﹤0.01% 1720
2020
Q2 		$1.99M Buy
133,271
+64,478
+94% +$921K ﹤0.01% 1645
2020
Q1 		$1.09M Buy
68,793
+1,319
+2% +$21.3K ﹤0.01% 1801
2019
Q4 		$1.09M Buy
67,474
+21,286
+46% +$355K ﹤0.01% 2055
2019
Q3 		$687K Buy
+46,188
New +$623K ﹤0.01% 2178
2017
Q1 		– Sell
-4,504
Closed -$60K – 3132
2016
Q4 		$60K Buy
+4,504
New +$60.3K ﹤0.01% 2956

Russell Investments Group's CBMG Position: Q1 2021 in Review

Russell Investments Group sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 108,545 shares — an estimated $1.99M sold.

Russell Investments Group first reported a position in CBMG in Q4 2016 and held it in 7 quarters. The position peaked at $1.99M in Q4 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

  • Russell Investments Group reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
  • Russell Investments Group sold 108,545 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $1.99M.
  • Russell Investments Group first reported a position in Cellular Biomedicine Group, Inc. in Q4 2016 and held it in 7 quarters.
  • Russell Investments Group's Cellular Biomedicine Group, Inc. position peaked at $1.99M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Russell Investments Group's 13F filing for Q1 2021, filed 10 May 2021.